XR or ER is short for extended-release which means the?pill is formulated so that the drug is released slowly over time.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Extended Release Drug industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Sustained Release Drug
Controlled Release Drug
Market Segment by Product Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Hisamitsu Pharmaceutical
Johnson & Johnson
Mallinckrodt
Mylan
Teva
Purdue Pharma
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Extended Release Drug consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Extended Release Drug market by identifying its various subsegments.
3.Focuses on the key global Extended Release Drug manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Extended Release Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Extended Release Drug submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Extended Release Drug Professional Survey Report Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Extended Release Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Extended Release Drug Segment by Type
2.1.1 Sustained Release Drug
2.1.2 Controlled Release Drug
2.2 Market Analysis by Application
2.2.1 Hospital Pharmacy
2.2.2 Retail Pharmacy
2.2.3 Online Pharmacy
2.3 Global Extended Release Drug Market Comparison by Regions (2016-2026)
2.3.1 Global Extended Release Drug Market Size (2016-2026)
2.3.2 North America Extended Release Drug Status and Prospect (2016-2026)
2.3.3 Europe Extended Release Drug Status and Prospect (2016-2026)
2.3.4 Asia-pacific Extended Release Drug Status and Prospect (2016-2026)
2.3.5 South America Extended Release Drug Status and Prospect (2016-2026)
2.3.6 Middle East & Africa Extended Release Drug Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Extended Release Drug Industry Impact
2.5.1 Extended Release Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Extended Release Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Extended Release Drug Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Extended Release Drug Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Extended Release Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Extended Release Drug Manufacturer Market Share
3.5 Top 10 Extended Release Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Extended Release Drug Market
3.7 Key Manufacturers Extended Release Drug Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Extended Release Drug Industry Key Manufacturers
4.1 Pfizer
4.1.1 Company Details
4.1.2 Pfizer Extended Release Drug Product Introduction, Application and Specification
4.1.3 Pfizer Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Hisamitsu Pharmaceutical
4.2.1 Company Details
4.2.2 Hisamitsu Pharmaceutical Extended Release Drug Product Introduction, Application and Specification
4.2.3 Hisamitsu Pharmaceutical Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Hisamitsu Pharmaceutical News
4.3 Johnson & Johnson
4.3.1 Company Details
4.3.2 Johnson & Johnson Extended Release Drug Product Introduction, Application and Specification
4.3.3 Johnson & Johnson Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Johnson & Johnson News
4.4 Mallinckrodt
4.4.1 Company Details
4.4.2 Mallinckrodt Extended Release Drug Product Introduction, Application and Specification
4.4.3 Mallinckrodt Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Mallinckrodt News
4.5 Mylan
4.5.1 Company Details
4.5.2 Mylan Extended Release Drug Product Introduction, Application and Specification
4.5.3 Mylan Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Mylan News
4.6 Teva
4.6.1 Company Details
4.6.2 Teva Extended Release Drug Product Introduction, Application and Specification
4.6.3 Teva Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Teva News
4.7 Purdue Pharma
4.7.1 Company Details
4.7.2 Purdue Pharma Extended Release Drug Product Introduction, Application and Specification
4.7.3 Purdue Pharma Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.5 Purdue Pharma News
4.8 Endo Pharmaceuticals
4.8.1 Company Details
4.8.2 Endo Pharmaceuticals Extended Release Drug Product Introduction, Application and Specification
4.8.3 Endo Pharmaceuticals Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Endo Pharmaceuticals News
4.9 Sun Pharmaceutical Industries
4.9.1 Company Details
4.9.2 Sun Pharmaceutical Industries Extended Release Drug Product Introduction, Application and Specification
4.9.3 Sun Pharmaceutical Industries Extended Release Drug Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Sun Pharmaceutical Industries News
5 Global Extended Release Drug Sales Categorized by Regions
5.1 Global Extended Release Drug Revenue, Sales and Market Share by Regions
5.1.1 Global Extended Release Drug Sales and Market Share by Regions (2016-2021)
5.1.2 Global Extended Release Drug Revenue and Market Share by Regions (2016-2021)
5.2 North America Extended Release Drug Sales and Growth Rate (2016-2021)
5.3 Europe Extended Release Drug Sales and Growth Rate (2016-2021)
5.4 Asia-pacific Extended Release Drug Sales and Growth Rate (2016-2021)
5.5 South America Extended Release Drug Sales and Growth Rate (2016-2021)
5.6 Middle East & Africa Extended Release Drug Sales and Growth Rate (2016-2021)
6 North America Extended Release Drug Market Size Categorized by Countries
6.1 North America Extended Release Drug Sales, Revenue and Market Share by Countries
6.1.1 North America Extended Release Drug Sales (Volume) by Countries (2016-2021)
6.1.2 North America Extended Release Drug Revenue by Countries (2016-2021)
6.1.3 United States Extended Release Drug Sales and Growth Rate (2016-2021)
6.1.4 Canada Extended Release Drug Sales and Growth Rate (2016-2021)
6.1.5 Mexico Extended Release Drug Sales and Growth Rate (2016-2021)
6.2 North America Extended Release Drug Revenue (Value) by Manufacturers
6.3 North America Extended Release Drug Sales and Market Share by Type (2016-2021)
6.4 North America Extended Release Drug Sales Market Share by Application (2016-2021)
7 Europe Extended Release Drug Market Size Categorized by Countries
7.1 Europe Extended Release Drug Sales, Revenue and Market Share by Countries
7.1.1 Europe Extended Release Drug Sales (Volume) by Countries (2016-2021)
7.1.2 Europe Extended Release Drug Revenue by Countries (2016-2021)
7.1.3 Germany Extended Release Drug Sales and Growth Rate (2016-2021)
7.1.4 UK Extended Release Drug Sales and Growth Rate (2016-2021)
7.1.5 France Extended Release Drug Sales and Growth Rate (2016-2021)
7.1.6 Russia Extended Release Drug Sales and Growth Rate (2016-2021)
7.1.7 Italy Extended Release Drug Sales and Growth Rate (2016-2021)
7.1.8 Spain Extended Release Drug Sales and Growth Rate (2016-2021)
7.2 Europe Extended Release Drug Revenue (Value) by Manufacturers
7.3 Europe Extended Release Drug Sales and Market Share by Type (2016-2021)
7.4 Europe Extended Release Drug Sales Market Share by Application (2016-2021)
8 Asia-Pacific Extended Release Drug Market Size Categorized by Countries
8.1 Asia-pacific Extended Release Drug Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Extended Release Drug Sales (Volume) by Countries (2016-2021)
8.1.2 Asia-pacific Extended Release Drug Revenue by Countries (2016-2021)
8.1.3 China Extended Release Drug Sales and Growth Rate (2016-2021)
8.1.4 South Korea Extended Release Drug Sales and Growth Rate (2016-2021)
8.1.5 Japan Extended Release Drug Sales and Growth Rate (2016-2021)
8.1.6 Australia Extended Release Drug Sales and Growth Rate (2016-2021)
8.1.7 India Extended Release Drug Sales and Growth Rate (2016-2021)
8.1.8 Southeast Asia Extended Release Drug Sales and Growth Rate (2016-2021)
8.2 Asia-pacific Extended Release Drug Revenue (Value) by Manufacturers
8.3 Asia-pacific Extended Release Drug Sales and Market Share by Type (2016-2021)
8.4 Asia-pacific Extended Release Drug Sales Market Share by Application (2016-2021)
9 South America Extended Release Drug Market Size Categorized by Countries
9.1 South America Extended Release Drug Sales, Revenue and Market Share by Countries
9.1.1 South America Extended Release Drug Sales (Volume) by Countries (2016-2021)
9.1.2 South America Extended Release Drug Revenue by Countries (2016-2021)
9.1.3 Brazil Extended Release Drug Sales and Growth Rate (2016-2021)
9.2 South America Extended Release Drug Sales and Market Share by Type (2016-2021)
9.3 South America Extended Release Drug Sales Market Share by Application (2016-2021)
10 Middle East and Africa Extended Release Drug Market Size Categorized by Countries
10.1 Middle East and Africa Extended Release Drug Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Extended Release Drug Sales (Volume) by Countries (2016-2021)
10.1.2 Middle East and Africa Extended Release Drug Revenue by Countries (2016-2021)
10.1.3 GCC Countries Extended Release Drug Sales and Growth Rate (2016-2021)
10.1.4 Turkey Extended Release Drug Sales and Growth Rate (2016-2021)
10.1.5 Egypt Extended Release Drug Sales and Growth Rate (2016-2021)
10.1.6 South America Extended Release Drug Sales and Growth Rate (2016-2021)
10.2 Middle East and Africa Extended Release Drug Sales and Market Share by Type
10.3 Middle East and Africa Extended Release Drug Sales Market Share by Application (2016-2021)
11 Global Extended Release Drug Market Segment by Type
11.1 Global Extended Release Drug Revenue, Sales and Market Share by Type (2016-2021)
11.1.1 Global Extended Release Drug Sales and Market Share by Type (2016-2021)
11.1.2 Global Extended Release Drug Revenue and Market Share by Type (2016-2021)
11.2 Sustained Release Drug Sales Growth Rate and Price
11.2.1 Global Sustained Release Drug Sales Growth Rate (2016-2021)
11.2.2 Global Sustained Release Drug Price (2016-2021)
11.3 Controlled Release Drug Sales Growth Rate and Price
11.3.1 Global Controlled Release Drug Sales Growth Rate (2016-2021)
11.3.2 Global Controlled Release Drug Price (2016-2021)
12 Global Extended Release Drug Market Segment by Application
12.1 Global Extended Release Drug Sales Market Share by Application (2016-2021)
12.2 Hospital Pharmacy Sales Growth Rate (2016-2021)
12.3 Retail Pharmacy Sales Growth Rate (2016-2021)
12.4 Online Pharmacy Sales Growth Rate (2016-2021)
13 Global Extended Release Drug Market Forecast
13.1 Global Extended Release Drug Revenue, Sales and Growth Rate (2021-2026)
13.2 Extended Release Drug Market Forecast by Regions (2021-2026)
13.2.1 North America Extended Release Drug Market Forecast (2021-2026)
13.2.2 Europe Extended Release Drug Market Forecast (2021-2026)
13.2.3 Asia-Pacific Extended Release Drug Market Forecast (2021-2026)
13.2.4 South America Extended Release Drug Market Forecast (2021-2026)
13.2.5 Middle East & Africa Extended Release Drug Market Forecast (2021-2026)
13.3 Extended Release Drug Market Forecast by Type (2021-2026)
13.3.1 Global Extended Release Drug Sales Forecast by Type (2021-2026)
13.3.2 Global Extended Release Drug Market Share Forecast by Type (2021-2026)
13.4 Extended Release Drug Market Forecast by Application (2021-2026)
13.4.1 Global Extended Release Drug Sales Forecast by Application (2021-2026)
13.4.2 Global Extended Release Drug Market Share Forecast by Application (2021-2026)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Extended Release Drug Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Extended Release Drug Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Extended Release Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Extended Release Drug
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Extended Release Drug Market Size by Type
Figure Global Market Share of Extended Release Drug by Type in 2020
Figure Sustained Release Drug Picture
Figure Controlled Release Drug Picture
Table Global Extended Release Drug Market Size (Volume) by Application
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Extended Release Drug Comparison by Regions (M USD) 2016-2026
Figure Global Extended Release Drug Market Size (Million US$) (2016-2026)
Figure North America Extended Release Drug Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Extended Release Drug Revenue (Million US$) Growth Rate (2016-2026)
Figure Asia-pacific Extended Release Drug Revenue (Million US$) Growth Rate (2016-2026)
Figure South America Extended Release Drug Revenue (Million US$) Growth Rate (2016-2026)
Figure Middle East & Africa Extended Release Drug Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Extended Release Drug Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Extended Release Drug Sales by Manufacturer (2016-2021)
Figure Global Extended Release Drug Sales Market Share by Manufacturer in 2020
Table Global Extended Release Drug Revenue by Manufacturer (2016-2021)
Figure Global Extended Release Drug Revenue Market Share by Manufacturer in 2020
Table Global Extended Release Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Extended Release Drug Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Extended Release Drug Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Extended Release Drug Market
Table Key Manufacturers Extended Release Drug Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Pfizer
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2016-2021
Table Pfizer Main Business
Table Pfizer Recent Development
Table Hisamitsu Pharmaceutical Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Hisamitsu Pharmaceutical
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hisamitsu Pharmaceutical 2016-2021
Table Hisamitsu Pharmaceutical Main Business
Table Hisamitsu Pharmaceutical Recent Development
Table Johnson & Johnson Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Johnson & Johnson
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2016-2021
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Mallinckrodt Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Mallinckrodt
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mallinckrodt 2016-2021
Table Mallinckrodt Main Business
Table Mallinckrodt Recent Development
Table Mylan Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Mylan
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2016-2021
Table Mylan Main Business
Table Mylan Recent Development
Table Teva Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Teva
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2016-2021
Table Teva Main Business
Table Teva Recent Development
Table Purdue Pharma Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Purdue Pharma
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Purdue Pharma 2016-2021
Table Purdue Pharma Main Business
Table Purdue Pharma Recent Development
Table Endo Pharmaceuticals Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Endo Pharmaceuticals
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Endo Pharmaceuticals 2016-2021
Table Endo Pharmaceuticals Main Business
Table Endo Pharmaceuticals Recent Development
Table Sun Pharmaceutical Industries Company Profile
Table Extended Release Drug Product Introduction, Application and Specification of Sun Pharmaceutical Industries
Table Extended Release Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharmaceutical Industries 2016-2021
Table Sun Pharmaceutical Industries Main Business
Table Sun Pharmaceutical Industries Recent Development
Figure Global Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Global Extended Release Drug Revenue and Growth Rate (2016-2021)
Table Global Extended Release Drug Sales by Regions (2016-2021)
Figure Global Extended Release Drug Sales Market Share by Regions in 2020
Table Global Extended Release Drug Revenue by Regions (2016-2021)
Figure Global Extended Release Drug Revenue Market Share by Regions in 2020
Figure North America Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Europe Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Asia-pacific Extended Release Drug Sales and Growth Rate (2016-2021)
Figure South America Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Middle East & Africa Extended Release Drug Sales and Growth Rate (2016-2021)
Figure North America Extended Release Drug Revenue and Growth Rate (2016-2021)
Table North America Extended Release Drug Sales (Volume) by Countries (2016-2021)
Table North America Extended Release Drug Sales Market Share by Countries (2016-2021)
Figure North America Extended Release Drug Sales Market Share by Countries in 2020
Table North America Extended Release Drug Revenue by Countries (2016-2021)
Table North America Extended Release Drug Revenue Market Share by Countries (2016-2021)
Figure North America Extended Release Drug Revenue Market Share by Countries in 2020
Figure United States Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Canada Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Mexico Extended Release Drug Sales and Growth Rate (2016-2021)
Table North America Extended Release Drug Revenue by Manufacturer (2020)
Figure North America Extended Release Drug Revenue Market Share by Manufacturer in 2020
Table North America Extended Release Drug Sales by Type (2016-2021)
Table North America Extended Release Drug Sales Share by Type (2016-2021)
Table North America Extended Release Drug Sales by Application (2016-2021)
Table North America Extended Release Drug Sales Share by Application (2016-2021)
Figure Europe Extended Release Drug Revenue and Growth Rate (2016-2021)
Table Europe Extended Release Drug Sales (Volume) by Countries (2016-2021)
Table Europe Extended Release Drug Sales Market Share by Countries (2016-2021)
Figure Europe Extended Release Drug Sales Market Share by Countries in 2020
Table Europe Extended Release Drug Revenue by Countries (2016-2021)
Table Europe Extended Release Drug Revenue Market Share by Countries (2016-2021)
Figure Europe Extended Release Drug Revenue Market Share by Countries in 2020
Figure Germany Extended Release Drug Sales and Growth Rate (2016-2021)
Figure UK Extended Release Drug Sales and Growth Rate (2016-2021)
Figure France Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Russia Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Italy Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Spain Extended Release Drug Sales and Growth Rate (2016-2021)
Table Europe Extended Release Drug Revenue by Manufacturer (2020)
Figure Europe Extended Release Drug Revenue Market Share by Manufacturer in 2020
Table Europe Extended Release Drug Sales by Type (2016-2021)
Table Europe Extended Release Drug Sales Share by Type (2016-2021)
Table Europe Extended Release Drug Sales by Application (2016-2021)
Table Europe Extended Release Drug Sales Share by Application (2016-2021)
Figure Asia-pacific Extended Release Drug Revenue and Growth Rate (2016-2021)
Table Asia-pacific Extended Release Drug Sales (Volume) by Countries (2016-2021)
Table Asia-pacific Extended Release Drug Sales Market Share by Countries (2016-2021)
Figure Asia-pacific Extended Release Drug Sales Market Share by Countries in 2020
Table Asia-pacific Extended Release Drug Revenue by Countries (2016-2021)
Table Asia-pacific Extended Release Drug Revenue Market Share by Countries (2016-2021)
Figure Asia-pacific Extended Release Drug Revenue Market Share by Countries in 2020
Figure China Extended Release Drug Sales and Growth Rate (2016-2021)
Figure South Korea Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Japan Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Australia Extended Release Drug Sales and Growth Rate (2016-2021)
Figure India Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Southeast Asia Extended Release Drug Sales and Growth Rate (2016-2021)
Table Asia-pacific Extended Release Drug Revenue by Manufacturer (2020)
Figure Asia-pacific Extended Release Drug Revenue Market Share by Manufacturer in 2020
Table Asia-pacific Extended Release Drug Sales by Type (2016-2021)
Table Asia-pacific Extended Release Drug Sales Share by Type (2016-2021)
Table Asia-pacific Extended Release Drug Sales by Application (2016-2021)
Table Asia-pacific Extended Release Drug Sales Share by Application (2016-2021)
Figure South America Extended Release Drug Revenue and Growth Rate (2016-2021)
Table South America Extended Release Drug Sales (Volume) by Countries (2016-2021)
Table South America Extended Release Drug Sales Market Share by Countries (2016-2021)
Figure South America Extended Release Drug Sales Market Share by Countries in 2019
Table South America Extended Release Drug Revenue by Countries (2016-2021)
Table South America Extended Release Drug Revenue Market Share by Countries (2016-2021)
Figure South America Extended Release Drug Revenue Market Share by Countries in 2019
Figure Brazil Extended Release Drug Sales and Growth Rate (2016-2021)
Table South America Extended Release Drug Sales by Type (2016-2021)
Table South America Extended Release Drug Sales Share by Type (2016-2021)
Table South America Extended Release Drug Revenue by Type (2016-2021)
Table South America Extended Release Drug Revenue Share by Type (2016-2021)
Table South America Extended Release Drug Sales by Application (2016-2021)
Table South America Extended Release Drug Sales Share by Application (2016-2021)
Figure Middle East and Africa Extended Release Drug Revenue and Growth Rate (2016-2021)
Table Middle East and Africa Extended Release Drug Sales (Volume) by Countries (2016-2021)
Table Middle East and Africa Extended Release Drug Sales Market Share by Countries (2016-2021)
Figure Middle East and Africa Extended Release Drug Sales Market Share by Countries in 2019
Table Middle East and Africa Extended Release Drug Revenue by Countries (2016-2021)
Table Middle East and Africa Extended Release Drug Revenue Market Share by Countries (2016-2021)
Figure Middle East and Africa Extended Release Drug Revenue Market Share by Countries in 2019
Figure GCC Countries Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Turkey Extended Release Drug Sales and Growth Rate (2016-2021)
Figure Egypt Extended Release Drug Sales and Growth Rate (2016-2021)
Figure South Africa Extended Release Drug Sales and Growth Rate (2016-2021)
Table Middle East and Africa Extended Release Drug Sales by Type (2016-2021)
Table Middle East and Africa Extended Release Drug Sales Share by Type (2016-2021)
Table Middle East and Africa Extended Release Drug Revenue by Type (2016-2021)
Table Middle East and Africa Extended Release Drug Revenue Share by Type (2016-2021)
Table Middle East and Africa Extended Release Drug Sales by Application (2016-2021)
Table Middle East and Africa Extended Release Drug Sales Share by Application (2016-2021)
Table Global Extended Release Drug Sales by Type (2016-2021)
Table Global Extended Release Drug Sales Market Share by Type (2016-2021)
Figure Global Extended Release Drug Sales Market Share by Type in 2020
Table Global Extended Release Drug Revenue by Type (2016-2021)
Table Global Extended Release Drug Revenue Market Share by Type (2016-2021)
Figure Global Extended Release Drug Revenue Market Share by Type in 2019
Figure Global Sustained Release Drug Sales Growth Rate (2016-2021)
Figure Global Sustained Release Drug Price (2016-2021)
Figure Global Controlled Release Drug Sales Growth Rate (2016-2021)
Figure Global Controlled Release Drug Price (2016-2021)
Table Global Extended Release Drug Sales by Application (2016-2021)
Table Global Extended Release Drug Sales Market Share by Application (2016-2021)
Figure Global Extended Release Drug Sales Market Share by Application in 2020
Figure Global Hospital Pharmacy Sales Growth Rate (2016-2021)
Figure Global Retail Pharmacy Sales Growth Rate (2016-2021)
Figure Global Online Pharmacy Sales Growth Rate (2016-2021)
Figure Global Extended Release Drug Sales and Growth Rate (2021-2026)
Figure Global Extended Release Drug Revenue and Growth Rate (2021-2026)
Table Global Extended Release Drug Sales Forecast by Regions (2016-2021)
Table Global Extended Release Drug Market Share Forecast by Regions (2016-2021)
Figure North America Sales Extended Release Drug Market Forecast (2021-2026)
Figure Europe Sales Extended Release Drug Market Forecast (2021-2026)
Figure Asia-Pacific Sales Extended Release Drug Market Forecast (2021-2026)
Figure South America Sales Extended Release Drug Market Forecast (2021-2026)
Figure Middle East & Africa Sales Extended Release Drug Market Forecast (2021-2026)
Table Global Extended Release Drug Sales Forecast by Type (2021-2026)
Table Global Extended Release Drug Market Share Forecast by Type (2021-2026)
Table Global Extended Release Drug Sales Forecast by Application (2021-2026)
Table Global Extended Release Drug Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Extended Release Drug
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Pfizer
Hisamitsu Pharmaceutical
Johnson & Johnson
Mallinckrodt
Mylan
Teva
Purdue Pharma
Endo Pharmaceuticals
Sun Pharmaceutical Industries